{
    "2018-07-18": [
        [
            {
                "time": "2018-07-18",
                "original_text": "Novartis Q2 Earnings Miss, Sales Top on Cosentyx, Entresto",
                "features": {
                    "keywords": [
                        "Q2",
                        "Earnings",
                        "Miss",
                        "Cosentyx",
                        "Entresto"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-19",
                "original_text": "FDA Oks Novartis' Kisqali For Use In Pre/Perimenopausal Women With Breast Cancer",
                "features": {
                    "keywords": [
                        "FDA",
                        "Kisqali",
                        "Approval",
                        "Breast Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-20",
                "original_text": "Novartis AG (NVS) Q2 2018 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Q2",
                        "Earnings",
                        "Conference Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "Novartis hints at 2018 outlook hike despite drug price freeze",
                "features": {
                    "keywords": [
                        "Outlook Hike",
                        "Drug Price Freeze",
                        "2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-22",
                "original_text": "Morgan Stanley gains on earnings; Novartis halts drug price hikes; Texas Instruments CEO steps down; Ford recalls 550K vehicles",
                "features": {
                    "keywords": [
                        "Morgan Stanley",
                        "Novartis",
                        "Drug Price Hikes",
                        "Halts"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-23",
                "original_text": "Novartis Earnings: 'A Focused Company Wins,' Says CEO",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Focused Company",
                        "CEO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}